{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:24:15Z","timestamp":1755221055125,"version":"3.43.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1023\/b:thro.0000003312.39877.17","type":"journal-article","created":{"date-parts":[[2003,11,14]],"date-time":"2003-11-14T15:35:11Z","timestamp":1068824111000},"page":"99-103","source":"Crossref","is-referenced-by-count":3,"title":["The Role of Glycoprotein IIb\/IIIa-Receptor Antagonists in Diabetics"],"prefix":"10.1007","volume":"15","author":[{"given":"Kurt","family":"Huber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5146239_CR1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"S Haffner","year":"1998","unstructured":"Haffner S, Lehto S, Ronnemaa T, Pyorala L, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and non-diabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339: 229-234.","journal-title":"N Engl J Med"},{"key":"5146239_CR2","volume-title":"Heart Disease in Diabetes Mellitus: Theory and Practise","author":"F Fein","year":"1990","unstructured":"Fein F, Scheur J. Heart Disease in Diabetes Mellitus: Theory and Practise. New York: Elsevier, 1990."},{"key":"5146239_CR3","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/0002-8703(85)90224-8","volume":"110","author":"L. Kannel W","year":"1985","unstructured":"Kannel W. Lipids, diabetes, and coronary heart disease; insights from the Framingham Study. Am Heart J 1985;110: 1100-1107.","journal-title":"Am Heart J"},{"key":"5146239_CR4","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/01.CIR.91.4.979","volume":"91","author":"B Stein","year":"1995","unstructured":"Stein B, Weintraub W, Gebhart S, et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 1995;91:979-989.","journal-title":"Circulation"},{"key":"5146239_CR5","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/01.CIR.94.8.1818","volume":"94","author":"KE Kip","year":"1996","unstructured":"Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Currier JW for the Investigators of the NHLBI PTCA Registry. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1996;94:1818-1825.","journal-title":"Circulation"},{"key":"5146239_CR6","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1161\/01.CIR.96.8.2551","volume":"96","author":"G Barsness","year":"1997","unstructured":"Barsness G, Peterson E, Ohman E, et al. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation 1997;96:2551-2556.","journal-title":"Circulation"},{"key":"5146239_CR7","doi-asserted-by":"crossref","unstructured":"Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1997;96:1761-1769.","DOI":"10.1161\/01.CIR.96.6.1761"},{"key":"5146239_CR8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0735-1097(97)00441-5","volume":"31","author":"W Weintraub","year":"1998","unstructured":"Weintraub W, Stein B, Kosinski A, et al. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. J AmColl Cardiol 1998;31:10-19.","journal-title":"J AmColl Cardiol"},{"key":"5146239_CR9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/01.CIR.99.5.633","volume":"99","author":"KM Detre","year":"1999","unstructured":"Detre KM, Guo P, Holubkov R, et al. Coronary revascularization in diabetic patients. A comparison of the randomized and oberservational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1999;99:633-640.","journal-title":"Circulation"},{"key":"5146239_CR10","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1053\/euhj.2000.2181","volume":"21","author":"Y Otsuka","year":"2000","unstructured":"Otsuka Y, Miyazaki S, Okumura H, et al. Abnormal glucose tolerance, not small vessel diameter, is a determinant of long-term prognosis in patients treated with balloon coronary angioplasty. European Heart Journal 2000;21:1790- 1796.","journal-title":"European Heart Journal"},{"key":"5146239_CR11","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0735-1097(00)00591-X","volume":"35","author":"D Hasdai","year":"2000","unstructured":"Hasdai D, Granger CB, Srivatsa SS, et al. Diabetes mellitus and outcome after primary coronary angioplasty for actue myocardial infarction: lessons from the GUSTO-IIb angioplasty substudy. J Am Coll Cardiol 2000;35:1502- 1512.","journal-title":"J Am Coll Cardiol"},{"key":"5146239_CR12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/hc3101.093700","volume":"104","author":"A Abizaid","year":"2001","unstructured":"Abizaid A, Costa MA, Centemero M, et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients.Insights from the arterial revascularization therapy studys (ARTS) trial. Circulation 2001;104:533-538.","journal-title":"Circulation"},{"key":"5146239_CR13","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0735-1097(93)90429-5","volume":"22","author":"EL Alderman","year":"1993","unstructured":"Alderman EL, Corley SD, Fisher LD, et al. The CASS Participating Investigators and Staff. Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). J AmColl Cardiol 1993;22:1141-1154.","journal-title":"J AmColl Cardiol"},{"key":"5146239_CR14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2337\/diacare.19.7.698","volume":"19","author":"J Herlitz","year":"1996","unstructured":"Herlitz J, Karlson B, Wognsen G, et al. Mortality and morbility in diabetic and non-diabetic patients during a 2-year period after coronary artery bypass grafting. Diabetes Care 1996;19:698-703.","journal-title":"Diabetes Care"},{"key":"5146239_CR15","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","volume":"330","author":"The EPIC Investigators.","year":"1994","unstructured":"The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty. New Engl J Med 1994;330:956-961.","journal-title":"New Engl J Med"},{"key":"5146239_CR16","doi-asserted-by":"crossref","unstructured":"Randomized placebo-controlled and balloon-angioplastycontrolled trial to assess safety of coronary stenting with the use of platelet glycoprotein IIb\/IIIa blockade. Lancet 1998;352:87-92.","DOI":"10.1016\/S0140-6736(98)85010-1"},{"key":"5146239_CR17","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1161\/01.CIR.97.19.1912","volume":"97","author":"NS Kleiman","year":"1998","unstructured":"Kleiman NS, Lincoff AM, Kereiakes DJ, et al. for the EPILOG Investigators. Diabetes mellitus, glycoprotein IIb\/IIIa blockade, and heparin. Evidence for a complex interaction in a multicenter trial. Circulation 1998;97:1912- 1920.","journal-title":"Circulation"},{"key":"5146239_CR18","first-page":"67","volume":"97","author":"RA. Cohen","year":"1993","unstructured":"Cohen RA. Dysfunction of vascular endothelium in diabetes mellitus. Circulation 1993;97:67-76.","journal-title":"Circulation"},{"key":"5146239_CR19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.91.3.635","volume":"91","author":"PJ Nasher","year":"1995","unstructured":"Nasher PJ, Brown RE, Oskarsson H, Winniford MD, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 1995;91:635-640.","journal-title":"Circulation"},{"key":"5146239_CR20","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0735-1097(97)00327-6","volume":"30","author":"I Yokoyama","year":"1997","unstructured":"Yokoyama I, Momomura S, Ohtake T, et al. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J AmColl Cardiol 1997;30:1472-1477.","journal-title":"J AmColl Cardiol"},{"key":"5146239_CR21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2362.1990.tb02264.x","volume":"20","author":"D Tschoepe","year":"1990","unstructured":"Tschoepe D, Roesen P, Kaufmann L, et al. Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. Eur J Clin Invest 1990;20:166-170.","journal-title":"Eur J Clin Invest"},{"key":"5146239_CR22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-2007-1002648","volume":"17","author":"A Strano","year":"1991","unstructured":"Strano A, Davi G, Patrono C. In vivo platelet activation in diabetes mellitus (review). Semin Thromb Haemost 1991;17:422-425.","journal-title":"Semin Thromb Haemost"},{"key":"5146239_CR23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-2007-1002650","volume":"17","author":"D Tschoepe","year":"1991","unstructured":"Tschoepe D, Roesen P, Esser J, et al. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Haemost 1991;17:433-438.","journal-title":"Semin Thromb Haemost"},{"key":"5146239_CR24","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/BF00401055","volume":"36","author":"A. Ceriello","year":"1993","unstructured":"Ceriello A. Coagulation activation in diabetes mellitus: a role of hyperglycemia and therapeutic prospects. Diabetologia 1993;36:1119-1125.","journal-title":"Diabetologia"},{"issue":"suppl","key":"5146239_CR25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2337\/diab.41.2.S26","volume":"2","author":"PD. Winocour","year":"1992","unstructured":"Winocour PD. Platelet abnormalities in diabetes mellitus. Diabetes 1992;suppl 2:26-31.","journal-title":"Diabetes"},{"key":"5146239_CR26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1055\/s-0038-1650578","volume":"76","author":"B Jilma","year":"1996","unstructured":"Jilma B, Fasching P, Ruthner C, et al. Elevated circulating P-selectin in insulin dependent diabetes mellitus. Thromb Haemost 1996;76:328-332.","journal-title":"Thromb Haemost"},{"key":"5146239_CR27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0049-3848(98)00050-4","volume":"90","author":"H Knobler","year":"1998","unstructured":"Knobler H, Savion N, Shenkman B, et al. Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients. Thromb Res 1998;90:181-190.","journal-title":"Thromb Res"},{"key":"5146239_CR28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0735-1097(99)00545-8","volume":"35","author":"M Shechter","year":"2000","unstructured":"Shechter M, Merz CN, Paul-Labrador MJ, et al. Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease. J Am Coll Cardiol 2000;35:300-307.","journal-title":"J Am Coll Cardiol"},{"key":"5146239_CR29","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s001250051556","volume":"43","author":"E Standl","year":"2000","unstructured":"Standl E, Schnell O. A new look at the heart in diabetes mellitus: from ailing to failing. Diabetologia 2000;43:1455-1469.","journal-title":"Diabetologia"},{"key":"5146239_CR30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/01.ATV.8.1.68","volume":"8","author":"J Auwerx","year":"1988","unstructured":"Auwerx J, Bouillon R, Collen D, et al. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 1988;8:68-72.","journal-title":"Arteriosclerosis"},{"key":"5146239_CR31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/diab.47.2.290","volume":"47","author":"J Calles-Escandon","year":"1998","unstructured":"Calles-Escandon J, Mirza SA, Sobel BE, et al. Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects. Diabetes 1998;47:290-293.","journal-title":"Diabetes"},{"key":"5146239_CR32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2337\/diab.43.1.104","volume":"43","author":"JB McGill","year":"1994","unstructured":"McGill JB, Schneider DJ, Arfken CL, et al. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 1994;43:104-109.","journal-title":"Diabetes"},{"key":"5146239_CR33","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/01.CIR.91.3.764","volume":"91","author":"TK Nordt","year":"1995","unstructured":"Nordt TK, Sawa H, Sobel BE. Induction of plasminogen activator inhibitor type-1 (PAC-1) by proinsulin and insulin in vivo. Circulation 1995;91:764-770.","journal-title":"Circulation"},{"key":"5146239_CR34","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1161\/01.CIR.97.22.2213","volume":"97","author":"BE Sobel","year":"1998","unstructured":"Sobel BE, Woodcock-Mitchell J, Schneider DJ, Holt RE, Marutsuka K, Gold H. Increased plasminogen activator inhibitor type-1 in coronary artery atherectomy specimens from type-2 diabetic compared with nondiabetic patients. Circulation 1998;97:2213-2221.","journal-title":"Circulation"},{"key":"5146239_CR35","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM199201303260506","volume":"326","author":"V Fuster","year":"1992","unstructured":"Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (part II). NEngl JMed 1992;326:310-318.","journal-title":"NEngl JMed"},{"key":"5146239_CR36","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199201233260406","volume":"326","author":"V Fuster","year":"1992","unstructured":"Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (part I). N Engl J Med 1992;326:242-250.","journal-title":"N Engl J Med"},{"key":"5146239_CR37","first-page":"647","volume":"12","author":"EL. Bierman","year":"1992","unstructured":"Bierman EL. Atherogenesis in diabetes. Atheroscler Thromb 1992;12:647-656.","journal-title":"Atheroscler Thromb"},{"key":"5146239_CR38","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/01.CIR.97.10.996","volume":"97","author":"J Ruige","year":"1998","unstructured":"Ruige J, Assendelft W, Dekker J, Kostense P, Heine R, Bouter L. Insulin and risk of cardiovascular disease. A metaanalysis. Circulation 1998;97:996-1001.","journal-title":"Circulation"},{"key":"5146239_CR39","first-page":"528","volume":"27","author":"D Aronson","year":"1996","unstructured":"Aronson D, Bloomgarden Z, Rayfield EJ. Potential mechanisms promoting restenosis in diabetic patients. JAmColl Cardiol 1996;27:528-535.","journal-title":"JAmColl Cardiol"},{"key":"5146239_CR40","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/hc3301.092789","volume":"104","author":"S-H Park","year":"2001","unstructured":"Park S-H, Marso SP, Zhou Z, Foroudi F, Topol EJ, Lincoff AM. Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin dependent diabetes mellitus. Circulation 2001;104:815-819.","journal-title":"Circulation"},{"key":"5146239_CR41","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1161\/01.CIR.96.5.1454","volume":"5","author":"E van Belle","year":"1997","unstructured":"van Belle E, Bauters C, Hubert E, et al. A comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 1997;5:1454-1460.","journal-title":"Circulation"},{"key":"5146239_CR42","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJM199506083322306","volume":"332","author":"J Lefkovits","year":"1995","unstructured":"Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb\/IIIa receptors in cardiovascular medicine. N Engl J Med 1995;332:1553-1559.","journal-title":"N Engl J Med"},{"key":"5146239_CR43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.CIR.104.2.163","volume":"104","author":"AM Lincoff","year":"2001","unstructured":"Lincoff AM, Kereiakes DJ, Mascelli MA, et al. Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization. Circulation 2001;104:163-167.","journal-title":"Circulation"},{"key":"5146239_CR44","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1073\/pnas.92.5.1505","volume":"92","author":"LR Languino","year":"1995","unstructured":"Languino LR, Duperray A, Joganic KJ, et al. Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc Natl Acad Sci USA 1995;92:1505-1509.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5146239_CR45","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/S0735-1097(99)00350-2","volume":"34","author":"FJ Neumann","year":"1999","unstructured":"Neumann FJ, Zohlnhofer D, Fakhoury L, et al. Effect of glycoprotein IIb\/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol 1999;34:1420-1426.","journal-title":"J Am Coll Cardiol"},{"key":"5146239_CR46","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/01.ATV.17.3.528","volume":"17","author":"DI Simon","year":"1997","unstructured":"Simon DI, Xu H, Ortlepp S, et al. 7E3 monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa crossreacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1. Arterioscler Thromb Vasc Biol 1997;17:528-535.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5146239_CR47","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/01.CIR.98.11.1085","volume":"98","author":"SH Tam","year":"1998","unstructured":"Tam SH, Sassoli PM, Jordan RE, et al. Abciximab (Reo-Pro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb\/IIIa and av\u00df3 integrins. Circulation 1998;98:1085-1091.","journal-title":"Circulation"},{"key":"5146239_CR48","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1172\/JCI119742","volume":"100","author":"C Weber","year":"1997","unstructured":"Weber C, Springer TA. Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1with fibrinogen bound to alpha-IIb beta-3 and stimulated by platelet activating factor. J Clin Invest 1997;100:2085-2093.","journal-title":"J Clin Invest"},{"key":"5146239_CR49","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/01.CIR.100.19.1977","volume":"100","author":"SR Steinhubl","year":"1999","unstructured":"Steinhubl SR, Kottke-Marchant K, Moliterno DJ, et al. Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients untergoing percutaneous coronary intervention. Circulation 1999;100:1977-1982.","journal-title":"Circulation"},{"key":"5146239_CR50","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1161\/01.CIR.102.20.2466","volume":"102","author":"P Th\u00b4eroux","year":"2000","unstructured":"Th\u00b4eroux P, Alexander J, Pharand C, et al. Glycoprotein IIb\/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina\/non-ST-elevation myocardial infarction. Circulation 2000; 102:2466-2472.","journal-title":"Circulation"},{"key":"5146239_CR51","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1161\/hc4801.100029","volume":"104","author":"M Roffi","year":"2001","unstructured":"Roffi M, Chew DP, Mukherjee D, et al. Platelet glycoprotein IIb\/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation 2001;104:2767-2771.","journal-title":"Circulation"},{"key":"5146239_CR52","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM199907293410503","volume":"341","author":"AM Lincoff","year":"1999","unstructured":"Lincoff AM, Califf RM, Moliterno DJ, Ellis SG, Ducas J, Kramer JH for the Evaluation of Platelet IIb\/IIIa Inhibition in Stenting investigators. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb\/IIIa receptors. N Engl J Med 1999;341:319-327.","journal-title":"N Engl J Med"},{"key":"5146239_CR53","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1161\/01.CIR.100.25.2477","volume":"100","author":"SP Marso","year":"1999","unstructured":"Marso SP, Lincoff AM, Ellis SG, et al. for the EPISTENT Investigators. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus. Results of the EPISTENT (Evaluation of Platelet IIb\/IIIa Inhibitor for Stenting Trial) diabetic study. Circulation 1999;100:2477-2784.","journal-title":"Circulation"},{"key":"5146239_CR54","first-page":"922","volume":"35","author":"DL Bhatt","year":"2000","unstructured":"Bhatt DL, Marso SP, Lincoff AM, Wolski KE, Ellis SG, Topol EJ. Abciximab reduces mortality in diabetics following percutaneous coronary intervention. JAmColl Cardiol 2000;35:922-928.","journal-title":"JAmColl Cardiol"},{"key":"5146239_CR55","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/01.CIR.96.2.367","volume":"96","author":"The RESTORE Investigators.","year":"1997","unstructured":"The RESTORE Investigators. Effects of platelet glycoprotein IIb\/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation 1997;96:367-368.","journal-title":"Circulation"},{"key":"5146239_CR56","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(96)10172-0","volume":"349","author":"The IMPACT Investigators.","year":"1997","unstructured":"The IMPACT Investigators. Randomized placebocontrolled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Lancet 1997;349:1422-1428.","journal-title":"Lancet"},{"key":"5146239_CR57","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/S0140-6736(00)03400-0","volume":"356","author":"The ESPRIT Investigators.","year":"2000","unstructured":"The ESPRIT Investigators. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomized, placebo-controlled trial. Lancet 2000;356:2037-2044.","journal-title":"Lancet"},{"key":"5146239_CR58","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/01.CIR.100.8.799","volume":"100","author":"The ERASER Investigators.","year":"1999","unstructured":"The ERASER Investigators. Acute platelet inhibition with abciximab does not reduce in-stent-restenosis (ERASER Study). Circulation 1999;100:799-806.","journal-title":"Circulation"},{"key":"5146239_CR59","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1161\/01.CIR.100.25.2466","volume":"100","author":"SB King","year":"1999","unstructured":"King SB, Mahmud E. Will blocking the platelet save the diabetic? Circulation 1999;100:2466-2468.","journal-title":"Circulation"},{"key":"5146239_CR60","doi-asserted-by":"crossref","first-page":"B5","DOI":"10.1016\/S1520-765X(03)90035-6","volume":"5","author":"M Laakso","year":"2003","unstructured":"Laakso M, Kuusisto J. Understanding patients need: diabetology for cardiologists. Eur Heart J 2003;5:B5-B13.","journal-title":"Eur Heart J"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:THRO.0000003312.39877.17.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/B:THRO.0000003312.39877.17\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:THRO.0000003312.39877.17.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T07:18:28Z","timestamp":1754637508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/B:THRO.0000003312.39877.17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["5146239"],"URL":"https:\/\/doi.org\/10.1023\/b:thro.0000003312.39877.17","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"type":"print","value":"0929-5305"},{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}